Parliamentary questions

Every parliamentary question asked in the 34th Dáil within the archive window, browsable by the department it was addressed to. Department names appear as printed in the official record. Questions also carry the questions paper's own subject heading. Browse those on the Topics page.

Questions by department

Addressed toQuestionsOralWrittenShare
Health 25,558 130 25,428
Education 12,997 131 12,866
Transport 10,233 127 10,106
Justice 9,003 122 8,881
Housing 8,661 147 8,514
Children 8,209 116 8,093
Finance 5,489 139 5,350
Social 5,425 121 5,304
Agriculture 4,588 123 4,465
Foreign 3,683 177 3,506
Enterprise 3,667 126 3,541
Climate 3,601 98 3,503
Public Expenditure 3,420 151 3,269
Further and Higher Education 3,269 127 3,142
Taoiseach 2,476 1,354 1,122
Defence 2,455 162 2,293
Culture 2,221 131 2,090
Rural 2,199 121 2,078
Environment 1,029 26 1,003
Tourism 703 31 672

Browse questions

Clear

25,558 questions match these filters · page 390 of 1,023

Ken O'Flynn written 2026-02-11 · to Health · Medicinal Products
318. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken or commissioned any assessment of the equity implications of current access arrangements for GLP-1 receptor agonist medicines for obesity or weight management, including the extent to which access is determined by capacity to pay out of pocket rather than clinical need; and whether the forthcoming national …
Ken O'Flynn written 2026-02-11 · to Health · Departmental Schemes
319. Deputy Ken O'Flynn asked the Minister for Health to provide the eligibility criteria, prescribing settings, and clinical governance requirements applying to the managed access system under which liraglutide (Saxenda) is reimbursed under the General Medical Services and Drugs Payment Schemes; and to provide the number of patients approved under this pathway in each of the years 2024 and 2025, …
Ken O'Flynn written 2026-02-11 · to Health · Medicinal Products
320. Deputy Ken O'Flynn asked the Minister for Health the current policy position of her Department on whether GLP-1 receptor agonist medicines for obesity or weight management should be eligible for reimbursement under the Drugs Payment Scheme, subject to health technology assessment and clinical governance; whether any policy review is under way in the context of the development of the new natio…
Ken O'Flynn written 2026-02-11 · to Health · Medicinal Products
321. Deputy Ken O'Flynn asked the Minister for Health whether the national obesity strategy currently in development will explicitly address the role of pharmacological treatment for obesity, including eligibility, reimbursement pathways, and equity of access; and whether she will outline how medicines policy is being aligned with the objectives of that strategy. [10660/26]
Pat Buckley written 2026-02-11 · to Health · Health Screening Programmes
322. Deputy Pat Buckley asked the Minister for Health to establish a national screening programme for prostate cancer, given the significance of early detection in improving health outcome, patient prognosis and quality of life. [10665/26]
Pat Buckley written 2026-02-11 · to Health · Medical Cards
323. Deputy Pat Buckley asked the Minister for Health to review and consider the provision of full medical cards for persons living with spinal injuries; and if she will make a statement on the matter. [10666/26]
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
324. Deputy Ken O'Flynn asked the Minister for Health whether her Department recognises that, for some people with disabilities and people receiving home-care supports, pharmacist-prepared monitored dosage systems, including blister packs, are clinically required to ensure safe medication administration and compliance; whether any national clinical guidance, policy circular, or Department-approved…
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
325. Deputy Ken O'Flynn asked the Minister for Health whether her Department has undertaken, or commissioned, any patient safety or risk assessment regarding the withdrawal or non-funding of pharmacist-prepared blister packs for people with disabilities or cognitive impairment who rely on such supports in a home-care setting; the findings of any such assessment; and if none has been undertaken, wh…
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
326. Deputy Ken O'Flynn asked the Minister for Health whether her Department has carried out a disability impact assessment, equality impact assessment, or human rights analysis in respect of the non-funding of monitored dosage systems, including blister packs, under the long-term Illness scheme; and if she will confirm whether the implications for people with disabilities living independently or …
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
327. Deputy Ken O'Flynn asked the Minister for Health when her Department first became aware that monitored dosage systems, including blister packs, were being provided to patients in practice while pharmacies claimed phased dispensing fees; the policy, governance, or compliance actions that were taken by her Department at that time; and if she will outline the Department’s oversight responsibilit…
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
328. Deputy Ken O'Flynn asked the Minister for Health what interim safeguards or guidance have been issued by her Department to ensure that patients with disabilities or complex medication needs do not experience disruption to medication compliance supports during the current pause in changes to phased dispensing arrangements; and whether clinicians or pharmacists have discretion to continue such …
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
329. Deputy Ken O'Flynn asked the Minister for Health the mechanism that exist, or are being considered, whereby a clinician, pharmacist, or multidisciplinary care team may formally certify that monitored dosage systems, including blister packs, are clinically necessary for an individual patient; and whether such certification would permit continued provision without cost to the patient under exis…
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
330. Deputy Ken O'Flynn asked the Minister for Health the way in which the non-funding of pharmacist-prepared blister packs aligns with national home-care policy objectives that support independent living for people with disabilities and older persons; and whether her Department accepts that medication compliance supports form an integral part of safe home-based care. [10674/26]
Ken O'Flynn written 2026-02-11 · to Health · Pharmacy Services
331. Deputy Ken O'Flynn asked the Minister for Health when her Department’s examination of the use of monitored dosage systems, including blister packs, will conclude; whether formal policy proposals will be published; and if she will commit to ensuring that any future framework explicitly addresses the needs of people with disabilities and those receiving home-care supports. [10675/26]
Ken O'Flynn written 2026-02-11 · to Health · State Properties
332. Deputy Ken O'Flynn asked the Minister for Health the total number of residential properties currently owned by the Health Service Executive which are vacant; the number deemed surplus to requirements; the length of time each property has been vacant; and if she will make a statement on the matter. [10678/26]
Ken O'Flynn written 2026-02-11 · to Health · State Properties
333. Deputy Ken O'Flynn asked the Minister for Health to outline the policy framework governing the retention, disposal, or repurposing of vacant residential properties owned by the Health Service Executive; when this policy was last reviewed; and if she will make a statement on the matter. [10679/26]
Ken O'Flynn written 2026-02-11 · to Health · Housing Provision
334. Deputy Ken O'Flynn asked the Minister for Health the formal engagement that has taken place between his Department, the Department of Housing, Local Government and Heritage, and the Land Development Agency regarding the potential transfer or reuse of vacant HSE-owned residential properties for housing purposes; and if she will make a statement on the matter. [10680/26]
Ken O'Flynn written 2026-02-11 · to Health · State Properties
335. Deputy Ken O'Flynn asked the Minister for Health to identify the principal legal, financial, or administrative barriers preventing the timely reuse or disposal of vacant residential properties owned by the Health Service Executive; the steps being taken to address these barriers; and if she will make a statement on the matter. [10681/26]
Ken O'Flynn written 2026-02-11 · to Health · State Properties
336. Deputy Ken O'Flynn asked the Minister for Health the annual cost to the State of maintaining vacant residential properties owned by the Health Service Executive, including security, insurance, and maintenance; and if she will make a statement on the matter. [10682/26]
Michael Fitzmaurice written 2026-02-11 · to Health · National Treatment Purchase Fund
337. Deputy Michael Fitzmaurice asked the Minister for Health the reason funding has been stopped under the National Treatment Purchase Fund for a person (details supplied); and if she will make a statement on the matter. [10688/26]
David Cullinane written 2026-02-11 · to Health · Departmental Data
338. Deputy David Cullinane asked the Minister for Health the expenditure at hospitals (details supplied) on taxis and private transport services for patient transfer, file transfer and other services identified as appropriate, for each of the years from 2021 to 2025 inclusive, in tabular form. [10710/26]
Thomas Gould written 2026-02-11 · to Health · General Practitioner Services
339. Deputy Thomas Gould asked the Minister for Health whether a general practitioner (GP) with a GMS contract can allow another GP in their practice, or a regularly employed locum, see a GMS patient; whether there are set hours for GPs under the GMS contract or if they can work to a minimum number of hours; and whether there is any provision for the agreement of a GMS contract for less than 40 ho…
John Paul O'Shea written 2026-02-11 · to Health · Health Service Executive
340. Deputy John Paul O'Shea asked the Minister for Health the amount of funding paid to a company (details supplied) by the HSE from 2020 to 2025 and to date in 2026 to provide a mobile x-ray service in partnership with the HSE in Cork; the number of mobile x-ray services provided for this funding; and if she will make a statement on the matter. [10718/26]
David Cullinane written 2026-02-11 · to Health · Ambulance Service
341. Deputy David Cullinane asked the Minister for Health the longest wait time recorded for an ambulance in each ambulance region in each year 2022-2025, in tabular form. [10719/26]
David Cullinane written 2026-02-11 · to Health · Ambulance Service
342. Deputy David Cullinane asked the Minister for Health the longest turnaround time recorded for an ambulance at each hospital in each year 2022-2025, in tabular form. [10720/26]
← Previous Next → page 390 of 1,023